XEVINAPANT

UNII:	N65WC8PXDD
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₂H₄₃N₅O₄
Preferred Substance Name:	XEVINAPANT
InChIKey:	LSXUTRRVVSPWDZ-MKKUMYSQSA-N
GSRS Full Record:	N65WC8PXDD i

1071992-99-8
(5S,8S,10aR)-N-(diphenylmethyl)-5-[(2S)-2-(methylamino)propanamido]-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide
(5S,8S,10aR)-N-benzhydryl-5-[[(2S)-2-(methylamino)propanoyl]amino]-3-(3-methylbutanoyl)-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide
AT-406
D-1143
DEBIO 1143
DEBIO-1143
IAP INHIBITOR AT-406
MSC2735845A
Pyrrolo[1,2-a][1,5]diazocine-8-carboxamide, N-(diphenylmethyl)decahydro-5-[[(2S)-2-(methylamino)-1-oxopropyl]amino]-3-(3-methyl-1-oxobutyl)-6-oxo-, (5S,8S,10aR)-
SM-406
XEVINAPANT [USAN]
Xevinapant
Xevinapant [WHO-DD]
xevinapant [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

XEVINAPANT

Synonyms and Mappings

Resources